ArcticZymes Technologies ASA
OSE:AZT.OL
Overview | Financials
Company Name | ArcticZymes Technologies ASA |
Symbol | AZT.OL |
Currency | NOK |
Price | 37.5 |
Market Cap | 1,907,677,500 |
Dividend Yield | 0% |
52-week-range | 24.2 - 79.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Marie Ann Roskrow BSc. (Hons), MBBS (Hons), Ph.D. |
Website | https://arcticzymes.com |
An error occurred while fetching data.
About ArcticZymes Technologies ASA
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD